1018 results Financial Regulation Services & Experience Financial Regulation Publications & Insights Financial Regulation People Financial Regulation Contact Capital Markets Services & Experience Capital Markets Publications & Insights Capital Markets People Capital Markets Contact ESG & Sustainability Services & Experience ESG & Sustainability Topics Banking and Finance Publications & Insights Banking and Finance People Banking and Finance Contact Infrastructure and Mobility Services & Experience Tax Alert - Further guidance on revised Dutch tax ruling practice On 23 April 2019 the Dutch State Secretary of Finance has published a draft decree (the "Decree") and further guidance on the revised Dutch tax ruling practice for tax rulings with an international character ("international tax rulings"), expected to beco Stibbe advises Andera Partners Stibbe advised Andera Partners in acquiring Infra Group NV from Waterland and the Verbraeken family and the subsequent MBO. Loyalty rebate scheme 'saved' by pharma company's market misconceptions The UK Competition and Markets Authority (CMA) recently closed its investigation into a discount scheme by dominant pharma company Merck Sharp & Dohme (MSD) aimed at preventing the National Health Service (NHS) from switching to competing biosimilars. Stibbe advises ABN AMRO Stibbe advises ABN AMRO on the sale of a majority stake in Stater to Infosys. Pagination Previous page Page 32 Current page 33 Page 34 Page 35 Next page
Tax Alert - Further guidance on revised Dutch tax ruling practice On 23 April 2019 the Dutch State Secretary of Finance has published a draft decree (the "Decree") and further guidance on the revised Dutch tax ruling practice for tax rulings with an international character ("international tax rulings"), expected to beco
Stibbe advises Andera Partners Stibbe advised Andera Partners in acquiring Infra Group NV from Waterland and the Verbraeken family and the subsequent MBO.
Loyalty rebate scheme 'saved' by pharma company's market misconceptions The UK Competition and Markets Authority (CMA) recently closed its investigation into a discount scheme by dominant pharma company Merck Sharp & Dohme (MSD) aimed at preventing the National Health Service (NHS) from switching to competing biosimilars.
Stibbe advises ABN AMRO Stibbe advises ABN AMRO on the sale of a majority stake in Stater to Infosys.